Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by a selective loss of dopaminergic neurons in the substantia nigra (SN). It has been suggested that microglial inflammation augments the progression of PD. Neuromelanin (NM), a complex polymer pigment found in catecholaminergic neurons, has sparked interest because of the suggestion that NM is involved in cell death in Parkinson's disease, possibly via microglia activation. To further investigate the possible role of NM in the pathogenesis of PD, we conducted in vivo experiments to find out whether microglial cells become activated after injection of human neuromelanin (NM) into (1) the cerebral cortex or (2) the substantia nigra to monitor in this PD-relevant model both microglial activation and possible neurodegeneration. In this study, adult male Wistar rats received an intracerebral injection of either NM, bacterial lipopolysaccharide (LPS, positive control), phosphate-buffered saline (PBS, negative control) or colloidal gold suspension (negative particular control). After different survival times (1, 8 or 12 weeks), brain slices from the cerebral cortex or substantia nigra (SN, 1 week) were stained with Iba-1 and/or GFAP antibody to monitor microglial and astrocytic reaction, and with tyrosine hydroxylase (TH) to monitor dopaminergic cell survival (SN group only). The injection of LPS induced a strong inflammatory response in the cortex as well in the substantia nigra. Similar results could be…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The archetype, riboflavin, acquires a dioxetane when illuminated, due to cycloaddition of 1O2* produced by excited riboflavin (115).”
From Chemiexcitation: Mammalian Photochemistry in the Dark† (2023) · cites this paper as [115]
In the citing paper
“FAD and FMN (flavin adenine dinucleotide and flavin mononucleotide) have electron transfer as their function (115), particularly in the mitochondria.”
From Chemiexcitation: Mammalian Photochemistry in the Dark† (2023) · cites this paper as [115]
In the citing paper
“In-vitro and in-vivo studies have confirmed the ability of neuromelanin to activate microglia and induce death of dopamine neurons.127,128”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [127]
In the citing paper
“In addition, the neuromelanin (dark, complex endogenous polymer derived from DA) can activate microglial cells, inducing neuroinflammation and neurodegeneration of dopaminergic neurons in PD (Zecca et al., 2008; Herrera et al., 2015).”
From The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma. (2017) · cites this paper as Zecca et al., 2008
In the citing paper
“Dopamine-derived quinones (DA-Q) can undergo intramolecular cyclization and oxidation to form leukochrome, aminochrome, and finally, neuromelanin, a pigment involved in neuroinflammation and neurodegeneration (Zecca et al. 2008).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Zecca et al. 2008
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045 · cited 5×
“Like other tissue macrophages in the Wrst line of host defence, microglia play a pivotal role as phagocytic, antigen-presenting cells acting in concert with invading immune cells to defend the immunological integrity of the CNS.”
InfluentialMicroglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557 · cited 1×
“, proteolytic enzymes, reactive oxygen intermediates (ROIs) or NO), and damage CNS cells [2, 4, 11, 21, 30].”
MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287 · cited 1×
“... protective functions, by, for example, supplying glial-derived neurotrophic factor (GDNF), interferons and tumor necrosis factor (TNF-), they may participate in an ongoing cell death following the initial toxic insult by releasing various kinds of noxious factors such as cytokines (i.e., TNF-, IL-1, IL-6) or proin…”
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · cited 1×
“, proteolytic enzymes, reactive oxygen intermediates (ROIs) or NO), and damage CNS cells [2, 4, 11, 21, 30].”
Banati, R. B., Gehrmann, J., Schubert, P., & Kreutzberg, G. W. (1993) · Glia · doi:10.1002/glia.440070117 · Cited by 1,029
Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791 · cited 2×
“In parkinsonian brains, also the regions receiving projections from substantia nigra like putamen have areas with microglial activation, which is secondary to the degeneration of the neuronal processes [14].”
Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403495101 · Cited by 495
Self-citation
Cited by
Items 101–200 of 230
Magnetic Resonance Imaging (MRI) in Parkinson′s Disease
Tuite, P. (2013) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.s1-001 · Cited by 33
Noelker, C., Hampel, H. J., & Dodel, R. C. (2011) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256398 · Cited by 32
Is Chelation Therapy a Potential Treatment for Parkinson’s Disease?
Ward, R. J., Dexter, D. T., Martín‐Bastida, A., & Crichton, R. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073338 · Cited by 32
Pain in Parkinson's disease: a neuroanatomy-based approach
Nardelli, D., Gambioli, F., Bartolo, M. I. D., Mancinelli, R., Biagioni, F., Carotti, S., Falato, E., Leodori, G., Puglisi‐Allegra, S., Vivacqua, G., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae210 · Cited by 32
More, S. V., Kumar, H., Kim, I., Koppula, S., Kim, B.-W., & Choi, D. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113129990059 · Cited by 32
Neurodegeneration models in Parkinson’s disease: cellular and molecular paths to neuron death
Álvarez‐Luquín, D. D., González-Fernández, R. R., Torres-Velasco, M. E., Ichikawa-Escamilla, E., Arce-Sillas, A., Martínez‐Martínez, E., Miranda-Narváez, C. L., Rodríguez-Ramírez, J. F., & Adalid-Peralta, L. V. (2025) · Behavioral and Brain Functions · doi:10.1186/s12993-025-00279-w · Cited by 31
Behl, T., Kaur, G., Sehgal, A., Zengin, G., Singh, S., Ahmadi, A., & BUNGAU, S. G. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210524152817 · Cited by 27
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s disease
Cai, W., Wakamatsu, K., Zucca, F. A., Wang, Q., Yang, K., Honarvar, N. M., Srivastava, P., Tanaka, H., Holly, G., Casella, L., et al. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102414 · Cited by 25
Self-citationLee, J. A., Son, H. J., Park, K. D., Han, S. H., Shin, N., Kim, J. H., Kim, H. R., Kim, D. J., & Hwang, O. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9550-z · Cited by 25
Wakamatsu, K., Tanaka, H., Tabuchi, K., Ojika, M., Zucca, F. A., Zecca, L., & Ito, S. (2014) · Molecules · doi:10.3390/molecules19068039 · Cited by 24
Self-citationSharma, P. K., Kishore, A., De, I., Negi, S., Kumar, G., Bhardwaj, S., & Singh, M. P. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105604 · Cited by 24
Spontaneous Formation of Melanin from Dopamine in the Presence of Iron
Hedges, D. M., Yorgason, J. T., Perez, A. W., Schilaty, N. D., Williams, B. M., Watt, R. K., & Steffensen, S. C. (2020) · Antioxidants · doi:10.3390/antiox9121285 · Cited by 24
The role of α-synuclein in neurodegeneration — An update
Jellinger, K. A. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0013-1 · Cited by 23
The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease
Burbulla, L. F., & Krainc, D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104545 · Cited by 23
Brain Damage - Bridging Between Basic Research and Clinics
González-Quevedo, A. (2012) · InTech eBooks · doi:10.5772/2174 · Cited by 22
Immune system and new avenues in Parkinson’s disease research and treatment
Nasrolahi, A., Safari, F., Farhoudi, M., Khosravi, A., Farajdokht, F., Bastaminejad, S., Shotorbani, S. S., & Mahmoudi, J. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0105 · Cited by 22
Littrell, O. M., Granholm, A., Gerhardt, G. A., & Boger, H. A. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.12.022 · Cited by 21
Pathology of Neurodegenerative Diseases
Kim, Y. S., Kim, Y.-K., Hwang, O., & Dong, J. (2012) · InTech eBooks · doi:10.5772/38028 · Cited by 21
Plini, E. R. G., Melnychuk, M. C., Andrews, R., Boyle, R. T., Whelan, R., Spence, J. S., Chapman, S. B., Robertson, I. H., & Dockree, P. M. (2024) · Acta Physiologica · doi:10.1111/apha.14191 · Cited by 20
Plum, S., Steinbach, S., Abel, L., Marcus, K., Helling, S., & May, C. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400030 · Cited by 20
Hassanein, L., Mulvey, B., Blankenship, H. E., Tish, M., Korukonda, A., Liles, L. C., Sharpe, A. L., Paré, J., Villalba, R. M., Chen, X., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.07.530845 · Cited by 20
Longitudinal neuromelanin changes in prodromal and early Parkinson’s disease in humans and rat model
Pérot, J., Ruze, A., Gaurav, R., Rebbah, S., Cadin, C., Troter, A. L., Soustelle, L., Mouton, L., Valabrègue, R., Parent, A., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf204 · Cited by 19
Zhang, S., Tao, K., Wang, J., Duan, Y., Wang, B., & Liu, X. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00216 · Cited by 18
Beardmore, R., Durkin, M., Zayee‐Mellick, F., Lau, L. C., Nicoll, J. A. R., Holmes, C., & Boche, D. (2024) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12965 · Cited by 18
Rubio, A. D., Hamilton, L. L., Bausch, M., Jin, M., Papetti, A. V., Jiang, P., & Yelamanchili, S. V. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10181-x · Cited by 17
Becchi, S., Buson, A., & Balleine, B. W. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02288-8 · Cited by 17
From pathogenesis to treatment: the emerging role of ferroptosis in Parkinson’s disease
Tu, R., Han, Z., Zhang, H., Jia, X., Sun, T., Liu, H., Li, J., Tang, M., & Wang, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1709561 · Cited by 17
A review: traditional herbs and remedies impacting pathogenesis of Parkinson’s disease
Sharma, V., Bedi, O., Gupta, M., & Deshmukh, R. R. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02223-5 · Cited by 17
Bacterial melanin increases electrical activity of neurons in Substantia Nigra pars compacta
Petrosyan, T., Chavushyan, V. A., & Hovsepyan, A. S. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1095-9 · Cited by 17
Chemiexcitation: Mammalian Photochemistry in the Dark†
Brash, D. E., & Goncalves, L. C. P. (2023) · Photochemistry and Photobiology · doi:10.1111/php.13781 · Cited by 16
Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology
Currim, F., Tanwar, R., Brown-Leung, J. M., Paranjape, N., Liu, J., Sanders, L. H., Doorn, J. A., & Cannon, J. R. (2024) · NeuroToxicology · doi:10.1016/j.neuro.2024.06.016 · Cited by 16
Blasco-Agell, L., Pons‐Espinal, M., Testa, V., Roch, G., Montero-Muñoz, J., Fernández‐Carasa, I., Baruffi, V., González-Sepúlveda, M., Richaud‐Patín, Y., Jiménez‐Delgado, S., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08544-4 · Cited by 15
Inflaming the diseased brain: a role for tainted melanins
Jeitner, T. M., Kalogiannis, M., Patrick, P. A., Gomolin, I. H., Palaia, T. A., Ragolia, L., Brand, D. A., & Delikatny, E. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.01.004 · Cited by 15
The neurobiological effects of senescence on dopaminergic system: A comprehensive review
Rocha, G. S., Freire, M. A. M., de Paiva, K. M., Oliveira, R. F., Morais, P. L. A. D. G., dos Santos, J. R., & Cavalcanti, J. R. L. D. P. (2024) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2024.102415 · Cited by 14
Carving the senescent phenotype by the chemical reactivity of catecholamines: An integrative review
Golubev, A. G. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101570 · Cited by 12
Neuromelanin inhibits CXCL10 expression in human astroglial cells
Tousi, N. S., Buck, D. J., Zecca, L., & Davis, R. L. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.09.042 · Cited by 11
Self-citationPromising molecular targets for pharmacological therapy of neurodegenerative pathologies
Неганова, М. Е., Aleksandrova, Y. R., Nebogatikov, V. O., Klochkov, S. G., & Ustyugov, A. A. (2020) · Acta Naturae · doi:10.32607/actanaturae.10925 · Cited by 11
Ashraf, A., Aljuhani, M., Hubens, C. J., Jeandriens, J., Parkes, H. G., Geraki, K., Mahmood, A., Herlihy, A. H., & So, P. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1393351 · Cited by 11
Neuroinflammation as a Potential Mechanism Underlying Parkinsons Disease
Cebrián, C., & Sulzer, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00008-0 · Cited by 11
Bush, W. D., Garguilo, J., Zucca, F. A., Bellei, C., Nemanich, R. J., Edwards, G. S., Zecca, L., & Simon, J. D. (2009) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2008.00476.x · Cited by 9
Self-citationMitra, R. S., Premraj, L., & Khoo, T. K. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105448 · Cited by 8
Biological Role of Neuromelanin in the Human Brain and Its Importance in Parkinson's Disease
Double, K. L., Maruyama, W., Naoi, M., Gerlach, M., & Riederer, P. F. (2011) · Wiley eBooks · doi:10.1002/9783527636150.ch8 · Cited by 7
D’Addario, S. L., Cenere, M. M., Cossa, F., Scaricamazza, S., Nesci, V., D’Ottavio, G., Caprioli, D., Ferri, A., Vila, M., Ledonne, A., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107378 · Cited by 7
Park, E., & Chun, H. S. (2016) · Journal of Life Science · doi:10.5352/jls.2016.26.6.640 · Cited by 7
Wallstein, N., Capucciati, A., Pöppl, A., Schnohr, C. S., Sturini, M., Pampel, A., Jäger, C., Zecca, L., Zucca, F. A., Monzani, E., et al. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202509102 · Cited by 7
Self-citationSubstantia nigra ferric overload and neuromelanin loss in Parkinson’s disease measured with 7T MRIPreprint
Rua, C., O’Callaghan, C., Ye, R., Hezemans, F. H., Passamonti, L., Jones, P. S., Williams, G. B., Rodgers, C. T., & Rowe, J. B. (2021) · medRxiv · doi:10.1101/2021.04.13.21255416 · Cited by 7
Muñoz, P., Meléndez, C., Paris, I. B., & Segura‐Aguilar, J. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13939-5_11 · Cited by 6
Magnetite particle size and spatial distribution may modulate neural oscillation in the human brain
Kletetschka, G., & Bazala, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-07988-2 · Cited by 6
The Treatment of Parkinson’s Disease with Sodium Oxybate
Mamelak, M. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467216666221103121135 · Cited by 6
Magnetic resonance imaging (MRI) methods in Parkinson's disease
Mangia, S., Michaeli, S., & Tuite, P. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139207294.003 · Cited by 6
Adult Endogenous Dopaminergic Neuroregeneration Against Parkinson’s Disease: Ideal Animal Models?
Vijayanathan, Y., Lim, S. M., Tan, M. P., Lim, F. T., Majeed, A. B. A., & Ramasamy, K. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00298-7 · Cited by 6
Neuromelanin-induced cellular stress and neurotoxicity in the pathogenesis of Parkinson's disease
Jakaria, M., & Cannon, J. R. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02156-3 · Cited by 6
PLA2: Implications in neurological disorders as a prospective therapeutic target
Premrajan, P., Jayanandan, A., & Variyar, E. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95696-3.00001-6 · Cited by 6
Pedersen, D. S., Locht, L. J., Tran, T. P., Markholt, S., Rungby, J., & Larsen, A. (2014) · PubMed · doi:10.14670/hh-29.10.447 · Cited by 6
Risk of Migraine in Europeans with Low Melanin Levels—A Population Based Case-Control Study
Kobus, M., Żądzińska, E., Sitek, A., Pełka, J., Rózniecki, J., & Antoszewski, B. (2022) · Brain Sciences · doi:10.3390/brainsci12050620 · Cited by 5
Neuropathology of Movement Disorders
Jellinger, K. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5316-3.00076-9 · Cited by 4
Goldeck, D., Schulte, C., dos Santos, M. C. T., Scheller, D., Oettinger, L., Pawelec, G., Deuschle, C., Berg, D., da Costa, A. N., & Maetzler, W. (2022) · Journal of Ageing and Longevity · doi:10.3390/jal3010001 · Cited by 4
Tejchman, A., Strzelec, M., Kot, M., Chlebanowska, P., Badyra, B., Sobocińska, M. K., Zecca, L., & Majka, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.28.538536 · Cited by 4
Self-citationInduction of Ferroptotic Cell Death by Neuromelanin Pigments in Dopaminergic Cells
Kaftan, G., & Armağan, G. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00029 · Cited by 4
Hussain, L., Masood, I., Ahmad, M., Ali, M. Y., Saleem, U., Hussain, M., Khalid, S. H., & Chauhdary, Z. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116678 · Cited by 4
Targeting PI3K/Akt/mTOR with fisetin mechanistic and therapeutics insights for Parkinson’s disease
Barik, S. K., Bansal, R., & Singh, S. (2025) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2026.100319 · Cited by 4
JS, O. O. O. (2014) · Journal of Biomolecular Research & Therapeutics · doi:10.4172/2167-7956.1000114 · Cited by 4
Genes involved in the development of Parkinson
Teixeira, D., & Cardoso, I. (2017) · Open Journal of Parkinson s Disease and Treatment · doi:10.17352/ojpdt.000005 · Cited by 3
NITRIC OXIDE MEDIATED NEURODEGENERATION IN PARKINSON’S DISEASE
Walia, V., & Kansotia, S. (2016) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2016.v9i5.11667 · Cited by 3
Esser, S., Hausherr, M., & Marcus, K. (2025) · Biomedicines · doi:10.3390/biomedicines13123048 · Cited by 3
Metabolic Plasticity of Astrocytes
Gorina, Y. V., Salmina, A. B., Erofeev, A. I., Can, Z., Bolshakova, A. V., Balaban, P. M., Борисович, Б. И., & Власова, О. Л. (2021) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093021060016 · Cited by 2
A Focus on the Link Between Metal Dyshomeostasis, Norepinephrine, and Protein Aggregation
Bacchella, C., Capucciati, A., & Monzani, E. (2025) · Antioxidants · doi:10.3390/antiox14030347 · Cited by 2
Determinants of Selective Vulnerability of Dopamine Neurons in Parkinson's Disease
Zampese, E., Galtieri, D. J., Schumacker, P. T., & Surmeier, D. J. (2016) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-802206-1.00041-6 · Cited by 2
Iron-Induced Dopaminergic Cell Death In Vivo as a Model of Parkinson’s Disease
Gerlach, M., Double, K. L., & Riederer, P. F. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_100-1 · Cited by 2
Effect of Tinospora cordifolia on neuroinflammation
Dhote, V. V., Kilor, V. A., Raja, M. K. M. M., Singhai, A., Mandloi, A. S., & Upaganlawar, A. B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90052-2.00019-6 · Cited by 2
Soares, J. D. J. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2
Recapitulating Parkinson’s disease pathology in a three-dimensional neural cell culture model
Taylor-Whiteley, T. R. (2019) · Sheffield Hallam University · doi:10.7190/shu-thesis-00321 · Cited by 1
Özata, G., Wise, R. M., Cardona‐Alberich, A., Mayeen, N. F., Müller, S. A., Lichtenthaler, S. F., Zecca, L., & Burbulla, L. F. (2026) · Scientific Reports · doi:10.1038/s41598-026-55648-w · Cited by 1
Self-citationPutative neuroprotective compounds in in vitro models of dopaminergic neurodegeneration
Ossola, B. (2011) · Helda - University of Helsinki Institutional Repository · Cited by 1
Salt marsh plants as source of bioactive compounds
Rocha, M. I. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
The role of microglia–lymphocyte interaction in PD neuropathology
Carta, A. R. (2012) · Basal Ganglia · doi:10.1016/j.baga.2012.07.003 · Cited by 1
Role of Wine Components in Inflammation and Chronic Diseases
Stockley, C. S. (2016) · Springer eBooks · doi:10.1007/978-3-319-24514-0_12 · Cited by 1
Iron-Induced Dopaminergic Cell Death In Vivo as a Model of Parkinson’s Disease
Gerlach, M., Double, K. L., & Riederer, P. F. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_100 · Cited by 1
Pepping, J. K. (2016) · Louisiana State University · doi:10.31390/gradschool_theses.1329 · Cited by 1
Ultrastructural and clinical features of central nervous system melanoma:Analysis of nine cases
Zhang, Q., Zhu, H., Zhang, C., Wang, Y., He, Y., & Li, G. (2021) · Ultrastructural Pathology · doi:10.1080/01913123.2021.1874083 · Cited by 1
Nanomaterials and Neurological Disorders Management
Sahu, S., Gantayat, D., Sahu, S. K., Kaur, G., Dwibedi, V., & Rath, S. K. (2024) · Smart nanomaterials technology · doi:10.1007/978-981-97-0308-1_5 · Cited by 1
Iron-Induced Dopaminergic Cell Death In Vivo as a Model of Parkinson’s Disease
Gerlach, M., Double, K. L., & Riederer, P. F. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_100 · Cited by 1
Fernández‐Espejo, E., Guerra, M., Castellano, S., de Fonseca, F. R., & de Pablos, Á. M. (2025) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.70112 · Cited by 1
Van, B. D. (2016) · theses.fr (ABES) · doi:10.70675/c5203fccz30cdz4b6dzb4fbzfb656e2a6448 · Cited by 1
Issa, S. A.-R. (2015) · theses.fr (ABES) · doi:10.70675/bac47709za653z4723z85f6z620ca3c186e3 · Cited by 1
Mayer, A. B. (2018) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Sanguigni, S., Paci, C., Carboni, T., Gobbato, R., D’Andreamatteo, G., Sobrini, S., Urbano, V., Brandimarti, A., & Curatola, L. (2009) · CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche) · Cited by 1
Étude moléculaire de l'inflammation chronique dans la maladie de Parkinson
Compagnion, A. (2019) · theses.fr (ABES) · doi:10.70675/04ca138dz3131z4e24z884czbba2f7954a99
Cancer immunotherapy : efficacy and safety of a melanin-based vaccine
Cuzzubbo, S. (2021) · theses.fr (ABES) · doi:10.70675/2e1d38a6z8d99z458dza769zb7bccda2b709
Gomes, C. A., George, J., Chen, J., & Cunha, R. A. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-20273-0_5
Public Relations Management Strategy for the Kalamazoo Institute of Arts
Locke, S. K. (1997)
Cook, N. L. (2010) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Ouattara, B., Angaman, D., & Coulibaly, A. (2013) · OA Biotechnology · doi:10.13172/2052-0069-2-3-984
Neuroinflammation and Cognitive Function: Mechanisms and Pathways
Sharma, K., & Veena, N. (2025) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-7432-0.ch009
Becchi, S., Buson, A., & Balleine, B. W. (2021) · Figshare · doi:10.6084/m9.figshare.16821686
Die Rolle von Neuromelanin in der Pathogenese desidiopathischen Parkinson Syndroms
Geick, S. (2011) · MACAU: Open Access Repository of Kiel University
Self-citation(2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32832cf9cb
Metadata
- Authors
- Zecca, L., Wilms, H., Geick, S., Claasen, J.-H., Brandenburg, L.-O., Holzknecht, C., Panizza, M. L., Zucca, F. A., Deuschl, G., Sievers, J., & Lucius, R.
- Affiliations
- Institute of Biomedical Technologies (IT)
- Heidelberg University (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- Corresponding author
- Lucius, Ralph
- Venue
- Acta Neuropathologica
- Published
- 2008-03-15
- Volume
- 116
- Issue
- 1
- Pages
- 47-55
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W1979975559
- Cited by
- 205
- References
- 37
- Citations by year
- 2026: 4 · 2025: 16 · 2024: 9 · 2023: 17 · 2022: 14 · 2021: 17 · 2020: 10 · 2019: 12 · 2018: 4 · 2017: 8 · 2016: 9 · 2015: 13 · 2014: 11 · 2013: 12 · 2012: 15
- FWCI
- 7.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- neuromelanin, Parkinson's disease, substantia nigra, microglial activation, neuroinflammation, neurodegeneration, dopaminergic neuron loss, catecholaminergic neurons, astrocyte activation, lipopolysaccharide, intracerebral injection, Iba1, tyrosine hydroxylase
- MeSH terms
- Animals, Humans, Immunohistochemistry, Inflammation, Male, Melanins, Nerve Degeneration, Neurons, Substantia Nigra, Tyrosine 3-Monooxygenase, Cell Death, Rats, Wistar, Microglia, Parkinsonian Disorders, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.